FORMAC strengthens management with appointment of CSO and COO
FORMAC Pharmaceuticals N.V. announced that Filip Kiekens will become the company’s new Chief Scientific Officer and that Laurent Schueller will become the company’s new Chief Operating Officer.
Filip Kiekens, Chief Scientific Officer
Dr. Filip Kiekens joins FORMAC from the Pharmaceutical Development Division of Johnson & Johnson (JANSSEN Pharmaceutica NV), where he led early and late development projects with increasing responsibilities. During his extensive research and development of complex active compounds, he was recognized with the JNJ Standards of Leadership award and the Philip B. Hofmann Research Scientist Award. For the successful development of INTELENCE®, a novel HIV drug, he was awarded the Johnson Medal, the most prestigious award given to scientists and technologists in Johnson & Johnson. As one of the Flanders District of Creativity Fellows, Filip merges his scientific passion of formulating complex molecules with his entrepreneurial spirit into business opportunities.
Filip graduated as a pharmacist in 1995 and holds a Ph.D. in Pharmaceutical Technology from the University of Ghent, Belgium.
Laurent Schueller, Chief Operating Officer
Dr. Laurent Schueller joins FORMAC Pharmaceuticals N.V. from Tibotec, where he was Chemical & Pharmaceutical Team Leader for the development of 2 late stage programs for the treatment of tuberculosis (TMC207) and HIV (TMC114). He was also involved in defining outsourcing strategies for the pharmaceutical development projects of Johnson and Johnson. Prior to his responsibilities in drug development, Laurent was responsible for budget management & control of a diverse portfolio of early and late development drugs. At FORMAC, Laurent will be responsible for the drug development programs and the associated operational activities.
Laurent graduated as a Pharmacist from the University of Strasbourg, France and holds a Ph.D. in Pharmaceutical Technology from the University of London, UK. He obtained his MBA from the Vlerick Business School in Belgium.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.